About hēRo3
hēRo3 is a Healthcare company based in Brookline (United States) founded in 2015, and was acquired by Fishawack in March 2022. It operates as a provider of clinical development and product planning software. hēRo3 offers products and services including hēRo3 Platform and hēRomod Package. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is Health Economics in R Online, LLC. Its competitors include Hawthorne Effect, MetricWire, Trials.ai, Strategikon Pharma and Drumroll Health and 4 more; 2 of its 9 listed competitors have raised funding.
Company details
hēRo3 was founded in 2015 and is based in Brookline, United States. Software solutions are offered by the company for clinical development and product planning within the healthcare technology sector. Tools are designed to support pharmaceutical and biotech operations, including trial management and strategic planning processes. Services are delivered through a web-based platform accessible via heroapps.io, targeting organizations involved in drug development and regulatory compliance.
- Headquarters Brookline, United States
- SectorsHealthcare
- Website heroapps.io
- Social LinkedIn YouTube
- Acquired by Fishawack (Mar 2022)
- Legal Name Health Economics In R Online, Llc
Products & Services of hēRo3
hēRo3 offers a comprehensive portfolio of products and services, including hēRo3 Platform and hēRomod Package.
Web-based tool for rapid HEOR model creation and secure execution.
Open-source package for running calculations in a secure cloud environment.
Apps and channels of hēRo3
its YouTube channel heRo3 has 20 subscribers and 30 videos.
Videos from hēRo3
The most watched videos on hēRo3's YouTube channel, heRo3 (20 subscribers). Click a video to play it here.
More on heRo3.
Investors in hēRo3
hēRo3 has secured backing from 1 investor. Prominent investors backing the company include Fishawack.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fully integrated cross-border services are delivered to global pharmaceutical organizations. | 2001 | fishawack.com | Brighton, United Kingdom |
Investor details for hēRo3
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of hēRo3
2 dated milestones of hēRo3 across 7 years, from founding to its latest funding, stage changes and deals.
- Founded hēRo3 is founded.
- Exit Acquired by Fishawack.
Competitors of hēRo3
hēRo3 has 9 listed competitors in our database, 2 of them funded. They include Hawthorne Effect, MetricWire, Trials.ai, Strategikon Pharma and Drumroll Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hawthorneeffect.com | 2015 | Lafayette, United States | – | 11 | Provides networks for accessible clinical trials with technology and site support. | |
| metricwire.com | 2013 | Kitchener, Canada | $120,000 | 5 | Online platform for researchers to collect data via the smartphone. | |
| trials.ai | 2014 | San Diego, United States | – | – | Provider of AI based trial management solution. | |
| strategikonpharma.com | 2016 | San Rafael, United States | – | – | Provides SaaS tools for streamlining clinical trial budgeting and vendor oversight. | |
| drumroll.health | 2012 | New York, United States | – | – | Provider of patient engagement services | |
| heartcorsolutions.com | 2015 | Schaumburg, United States | – | – | Provides expert ECG recording and analysis for clinical research safety studies. | |
| xclinical.com | 2002 | Munich, Germany | – | – | Clinical software solution provider for study design | |
| novainsilico.ai | 2010 | Lyon, France | – | – | Developer of AI-driven in silico clinical trial platform for improving decision-making in biology, medicine, and data science | |
| adaptichealth.io | 2021 | Mountain View, United States | $100,000 | – | Software solutions for clinical trial design are provided. |
Detailed competitors of hēRo3
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of hēRo3
The website of hēRo3 (heroapps.io) receives about 3.2K visits a month.
- Monthly visits3.2K
▲ 98.6% vs previous month
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as hēRo3 (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about hēRo3
hēRo3 was founded in 2015.
hēRo3 is headquartered in Brookline, United States. It is registered at Brookline, Massachusetts, United States.
hēRo3 was founded in 2015 and is based in Brookline, United States. Software solutions are offered by the company for clinical development and product planning within the healthcare technology sector. Tools are designed to support pharmaceutical and biotech operations, including trial management and strategic planning processes. Services are delivered through a web-based platform accessible via heroapps.io, targeting organizations involved in drug development and regulatory compliance.
hēRo3's top competitors include MetricWire, Trials.ai and Nova In Silico.
hēRo3 offers hēRo3 Platform and hēRomod Package.
hēRo3 has 1 investor. Key investors include Fishawack.
hēRo3 operates through Health Economics In R Online, Llc.
Yes. hēRo3 was acquired by Fishawack in March 2022.